Document is current
Any future updates will be listed below
-
Authors
Crouzet, Laetitia
Gramond, Anne
Suehs, Carey
Fabbro-Peray, Pascale
Abbar, Mocrane
Lopez-Castroman, Jorge https://orcid.org/0000-0003-0618-0690
-
Funding
Funding for this research was provided by:
Direction Générale de l’offre de Soins (PHRCN 16-0119)
- License Information
-
More Information
Article History
Received: 26 March 2021
Accepted: 26 December 2021
First Online: 28 January 2022
Declarations
:
: The research has been implemented after a favorable opinion from the Competent Authority and the CPP TOURS - Région Centre - Ouest 1, , IRB n° IORG0008143 OMB : 0990-0279) and the information of the “Agence Nationale de Sécurité du Médicament et des Produits de Santé” (ANSM), in France. This is a biomedical research protocol requiring the informed consent of participants. An informative letter is presented to the participant stating the purpose, the objectives, and conduct of the study in accordance with current regulations and their rights to refuse to participate or leave the study at any time. Patient consent is sought and obtained before the entry thereof in the study. The investigators are responsible for correctly informing patients/subjects and obtaining their informed consent. Participant children sign a consent form adapted to their age (6–11 and 11–15 years) and their parents too. The approval of these consent forms can be found in the validation letter by the CPP.
: Informed consent materials will be available from the corresponding author on request.
: The authors declare that they have no competing interests.
